Rationale and design of the AdRem study: Evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus

RP (Ronald) Stolk; Hans Vingerling; JK Cruickshank; AD Hughes; A Stanton; JM Lu; A Patel; SAM Thom; DE (Diederick) Grobbee

doi:10.1016/j.cct.2006.08.011

Rationale and design of the AdRem study: Evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus

RP (Ronald) Stolk, Hans Vingerling, JK Cruickshank, AD Hughes, A Stanton, JM Lu, A Patel, SAM Thom, DE (Diederick) Grobbee

Research output: Contribution to journal › Article › Academic › peer-review

18 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	6-17
Number of pages	12
Journal	Contemporary Clinical Trials
Volume	28
Issue number	1
DOIs	https://doi.org/10.1016/j.cct.2006.08.011
Publication status	Published - 2007

Research programs

EMC OR-01-60-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.cct.2006.08.011

http://hdl.handle.net/1765/37063

Cite this

Stolk, RP., Vingerling, H., Cruickshank, JK., Hughes, AD., Stanton, A., Lu, JM., Patel, A., Thom, SAM., & Grobbee, DE. (2007). Rationale and design of the AdRem study: Evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus. Contemporary Clinical Trials, 28(1), 6-17. https://doi.org/10.1016/j.cct.2006.08.011

@article{88124dd28db04a4bb35d8f310df579ee,

title = "Rationale and design of the AdRem study: Evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus",

author = "Stolk, {RP (Ronald)} and Hans Vingerling and JK Cruickshank and AD Hughes and A Stanton and JM Lu and A Patel and SAM Thom and Grobbee, {DE (Diederick)}",

year = "2007",

doi = "10.1016/j.cct.2006.08.011",

language = "Undefined/Unknown",

volume = "28",

pages = "6--17",

journal = "Contemporary Clinical Trials",

issn = "1551-7144",

publisher = "Elsevier Inc.",

number = "1",

}

Stolk, RP, Vingerling, H, Cruickshank, JK, Hughes, AD, Stanton, A, Lu, JM, Patel, A, Thom, SAM & Grobbee, DE 2007, 'Rationale and design of the AdRem study: Evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus', Contemporary Clinical Trials, vol. 28, no. 1, pp. 6-17. https://doi.org/10.1016/j.cct.2006.08.011

Rationale and design of the AdRem study: Evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus. / Stolk, RP (Ronald); Vingerling, Hans; Cruickshank, JK et al.
In: Contemporary Clinical Trials, Vol. 28, No. 1, 2007, p. 6-17.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Rationale and design of the AdRem study: Evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus

AU - Stolk, RP (Ronald)

AU - Vingerling, Hans

AU - Cruickshank, JK

AU - Hughes, AD

AU - Stanton, A

AU - Lu, JM

AU - Patel, A

AU - Thom, SAM

AU - Grobbee, DE (Diederick)

PY - 2007

Y1 - 2007

U2 - 10.1016/j.cct.2006.08.011

DO - 10.1016/j.cct.2006.08.011

M3 - Article

C2 - 17030155

SN - 1551-7144

VL - 28

SP - 6

EP - 17

JO - Contemporary Clinical Trials

JF - Contemporary Clinical Trials

IS - 1

ER -